Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells. (April 2014)
- Record Type:
- Journal Article
- Title:
- Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells. (April 2014)
- Main Title:
- Exenatide protects against hypoxia/reoxygenation-induced apoptosis by improving mitochondrial function in H9c2 cells
- Authors:
- Chang, Guanglei
Zhang, Dongying
Liu, Jian
Zhang, Peng
Ye, Lin
Lu, Kai
Duan, Qin
Zheng, Aihua
Qin, Shu - Abstract:
- Glucagon-like peptide-1 (GLP-1) analogues might exert the cardioprotective effects via attenuating apoptosis. This study aimed to determine the protective effects and mechanism of exenatide, a GLP-1 analogue, on cardiomyocyte apoptosis using an in vitro model of hypoxia/reoxygenation (H/R). H9c2 cells were employed to establish an in vitro model of H/R. 200 nM exenatide pretreatment significantly reduced apoptosis measured by flow cytometry. To further study the antiapoptotic mechanism of exenatide, we used flow cytometry in combination with laser confocal microscopy to determine the interaction between exenatide and the process of mitochondria-mediated apoptosis. We found that exenatide pretreatment reduced the intracellular reactive oxygen species (ROS) levels and decreased the mitochondrial calcium overload caused by H/R. Furthermore, an increase of total superoxide dismutase (T-SOD) levels, a decrease of malondialdehyde (MDA) levels, a preservation of mitochondrial membrane potential (ΔΨm), a reduction of cytochrome-c release, a decline of cleaved caspase-3 expression, and caspase-3 activation were observed in exenatide-pretreated cultures. These results suggest that exenatide exerts a protective effect on preventing against H/R-induced apoptosis. Importantly, the protective effects of exenatide may be attributed to its role in improving mitochondrial function in H9c2 cells subjected to H/R.
- Is Part Of:
- Experimental biology and medicine. Volume 239:Number 4(2014:Apr.)
- Journal:
- Experimental biology and medicine
- Issue:
- Volume 239:Number 4(2014:Apr.)
- Issue Display:
- Volume 239, Issue 4 (2014)
- Year:
- 2014
- Volume:
- 239
- Issue:
- 4
- Issue Sort Value:
- 2014-0239-0004-0000
- Page Start:
- 414
- Page End:
- 422
- Publication Date:
- 2014-04
- Subjects:
- GLP-1 analogue -- exenatide -- hypoxia/reoxygenation -- cardiomyocyte apoptosis -- mitochondria
Physiology -- Periodicals
Biology, Experimental -- Periodicals
Medicine, Experimental -- Periodicals
610.72 - Journal URLs:
- http://ebm.rsmjournals.com/ ↗
http://ebm.sagepub.com/ ↗
http://www.ebmonline.org ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/1535370214522177 ↗
- Languages:
- English
- ISSNs:
- 1535-3702
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5607.xml